Sr. No. 

Title of Project

Proposal No. (IEC No.)

Name of Principle Investigator

Amount of Grant Received

Name of Funding Agency

Collaboration with other institute (if any)

Status of Project (Ongoing/ Completed)

Publication (YES/NO)

1

Anti-anxiety effect of Escitalopram and Desvenlafaxine and its correlation with serum BDNF level in depression with comorbid anxiety – A randomized, open-label clinical study

IEC/Pharmac/2021/308

Dr Chaitali Chindhalore

INR 78,000

AIIMS Nagpur (Intramural)

NA

Completed (Sent for publication)

No

2

Evaluating effect of Escitalopram and Desvenlafaxine on anxiety and BDNF level in depression with comorbid anxiety – An open label, randomized, parallel group, clinical study

IEC/2021/187

Chindhalore CA

Co PI:

Dakhale GA, Snehalata Gajbhiye, Gupta A

0.8 lakhs

Intramural funding (AIIMS Nagpur)

Ongoing

No

Sr. No. 

Title of Project

Proposal No. (IEC No.)

Name of Principle Investigator

Amount of Grant Received

Name of Funding Agency

Collaboration with other institute (if any)

Status of Project (Ongoing/ Completed)

Publication (YES/NO)

1

Exploring Ayurvedic Combinations & Natural compound in the treatment of Oral premalignant lesions & oral cancer & integration with Modern medicine: A pilot study

IEC/2025/629

Dr Kiran kumar Prathipati

Co-PI

Dr Anant Khot

60.69 lakh

ICMR

Regional Ayurveda Research Institute, Nagpur

Ongoing

No

2

Effectiveness of millet based supplementary nutrition on the nutrition status of preschool children aged 3yrs to 6 yrs attending Anganwadi centres under the Integrated Child Development Project in the rural population in Nagpur district, Maharashtra

IEC/Pharma/2023/619

Dr Ranjan Solanki

Dr Chaitali Chindhalore(Co-PI)

INR 29,36,850

DST

NA

ongoing           

No

3

Efficacy of Classical Ayurvedic treatment (CAT) as add-on to conventional bio-medicine to determine improvement in quality of life (QoL) and recurrence-free-survival in head-neck-cancer (HNC) patients.

IEC/2025/643

Gayatri Muthiyan

Co PI:

Gugapriya, Tarnekar A, Vijaygeetha, Snehalata Gajbhiye  

5 Cr

ICMR-AYUSH

Ongoing

No

Evaluation of effect of atypical antidepressants on brain neuroinflammation in a model of depression in rats                         

PJLCP/2021-22/IAEC/35

Snehalata Gajbhiye

0.9 lakhs

Intramural funding (AIIMS Nagpur)

Ongoing

No

Evaluation of effect of Hydroxyurea treatment on inflammatory markers and oxidative stress markers among adults with sickle cell disease: A prospective observational study

IEC/2024/398

Anusha B

Co PI: Snehalata Gajbhiye

Rs. 1 lakh

ICMR-PG thesis funding

Ongoing

No

Sr. No. 

Title of Project

Proposal No. (IEC No.)

Name of Principle Investigator

Amount of Grant Received

Name of Funding Agency

Collaboration with other institute (if any)

Status of Project (Ongoing/ Completed)

1

Comparison of Efficacy and Safety of Intravenous Ferric Carboxymaltose Versus Intravenous Iron (III) Isomaltoside 1000 in the Treatment of Patients with Moderate to Severe Iron Deficiency Anemia: A Prospective, Randomized, Open-Labelled, Active Controlled Study

IEC/AIIMS-N/2024/056).

Dr Anant Khot

Co PI:

Dr. Nandini A

1 lakh

ICMR

Nil

Completed

2

FIW-2024-01-00000788 Targeting Lung cancer cells with Panchagavya conjugated PDL1 blocking peptides through Polyoxometalate (POM) Quantum-Container Derived
Liposomes

IEC/2025/01

Satyendra Tripathi

Co PI:

Somnath Garai, Amit Nakanekar, Snehalata Gajbhiye

70 lakhs

ICMR

Ongoing

Sr. No. 

Title of Project

Proposal No. (IEC No.)

Name of Principle Investigator

Amount of Grant Received

Name of Funding Agency

Collaboration with other institute (if any)

Status of Project (Ongoing/ Completed)

Publication (YES/NO)

1

Evaluating Safety, Optimal Dose, and Efficacy of Innovative Neck Chamber Device for Noninvasive Mechanical Baroreflex Activation Therapy in Patients with Compensated Heart Failure: Multiphase RCT

IEC/Pharma/2025/626

Dr Prathamesh Kamble

Dr Chaitali Chindhalore(Co-PI)

1.44 Cr

ICMR

NA

ongoing

No

2

Optimising Letrozole Dose and Duration for Ovulation Induction in Infertile Women with PCOS: A Multicentric, Triple-Blind, Placebo-Controlled RCT (OLIO-PCOS Trial).

IEC/Pharma/2025/1781

Dr. Anita Yadav 

Co PI:

Dr Chaitali Chindhalore

16,40,553/-

ICMR

AIIMS Delhi

Ongoing

No

A double-blind parallel-arm randomized controlled trial to evaluate the efficacy and safety of Bedaquiline in combination with Multi-drug therapy in individuals with Multibacillary Leprosy Clinical validation study of medical device-Cerviscan

Yet to be approved by IEC

Dr Gitesh Sawatkar 

Dr Chaitali Chindhalore(Co-PI)

ICMR INTENT

Multicentric

Ongoing

No

Clinical validation study of medical device-Cerviscan

Yet to be approved by IEC

Dr Anita Yadav 

Dr Chaitali Chindhalore(Co-PI)

ICMR-INTENT

Multicentric

Ongoing

No

Mapping Academic and Industry Sponsorship in CTRI Drug Trials: Evaluating Therapeutic Focus and National Healthcare Alignment

STS2025-10530

Snehalata Gajbhiye

Rs. 60,000

ICMR-STS

Ongoing

No

Sr. No.

Title of Project

Clinical Trial No.

Name of Principle Investigator 

Amount Received 

Sponsors

Status of Project (Ongoing/ Completed)

Publication (YES/NO)

Multi-center, randomized, parallel group, active controlled, open label clinical trial to evaluate efficacy and safety of fixed dose combination syrup of bilastine 3.3 mg, dextromethorphan 10 mg and phenylephrine 5 mg per 5 ml, in patients with cough associated with common cold allergy.

IECCT/Pharmac/2023/299

Dr. Ganesh Dakhale

17550/- per subject(10 subjects randomized at our site)

Glenmark Pharmaceuticals limited

Completed

No

A Phase III , Prospective , Randomized, open label , Active controlled, Parallel group , Multicentre Clinical Study to Evaluate the Efficacy, Safety and Tolerability of a fixed Dose Combination of  Vildagliptin and Dapagliflozin Tablet 50mg/5mg of USV Private Ltd, India as compared to Concomitant Administration of Reference Product, Galvus 50mg tablet (Vildagliptin) of Novartis Pharmaceuticals UK Ltd , along with Forxiga 5mg tablet(Dapagliflozin) of AstraZeneca  Pharmaceuticals , USA in patients with type 2 Diabetes Mellitus Inadequately Controlled on earlier metformin containing dual therapy.

IECCT/Pharmac/2022/365

Dr. Amol Dube (PI)        

 Dr. Ganesh Dakhale (Co-I)

INR 23615 per patient grant

USV Private Limited

Completed

No

A randomized, double- blind, placebo-controlled, multicentre, phase III clinical trial to evaluate the efficacy and safety of Prandial Technosphere® insulin inhalation powder versus placebo inhalation powder in patients with type 2 diabetes mellitus inadequately controlled with oral anti-diabetic drugs over a 24-week treatment period.

IECCT/Pharma/2022/166

Dr. Bharat Singh Rathod (PI)    

Dr. Ganesh Dakhale (Co-I)

INR 83050 per patient grant

Cipla Ltd

Terminated by Sponsor

No

A prospective, multicenter, open label, phase IV, interventional study to assess the safety and efficacy of capmatinib in Indian patients with mesenchymal- epithelial transition (MET) exon 14 skipping mutation positive advanced non small cell lung cancer (NSCLC).

IECCT/Pharmac/2022/187

Dr. Vandana Singh Kushwaha (PI)        

Dr. Ganesh Dakhale -Co-I

INR 101250 per subject cost

Novartis Healthcare Pvt Ltd.

Closed

No

A prospective, randomized, multicenter, comparative, double-blind, parallel study to evaluate the efficacy, safety, pharmacokinetics and immunogenicity of biosimilar Pertuzumab (ENZENE) with reference Pertuzumab (Perjeta®, Genentech Inc.,) in previously untreated patients with HER2 positive metastatic breast cancer.

IECCT/Pharmac/2023/287

Dr. Vandana Singh  Kushwaha (PI)                     

Dr. Ganesh Dakhale -Co-I

INR 2,50,480 per subject cost

Enzene Bioscience      Co-Sponsor- Alkem Laboratories

Closed

No

A Phase 3, Multicentre, randomized, double-blind, double-dummy, parallel-group, active controlled study to compare the efficacy and safety of a fixed dose combination of Metformin hydrochloride 1000mg ER, Sitagliptin phosphate 100mg and Dapagliflozin Propanediol 10 mg tablets versus Janumet XR CP (Combipack of Metformin hydrochloride 1000 mg SR and Sitagliptin Phosphate 100mg ) in patients with Type 2 Diabetes Mellitus (T2 DM)”.

IECCT/Pharma/2022/143

Dr. Sunita Kumbhalkar (PI)  

Dr. Chaitali Chindhalore (Co-I)

INR 43250 per subject

Alkem Laboratories Ltd.

Completed

No

A randomized, double-blind, multicenter, three-arm, placebo-controlled, parallel-design, bioequivalence study with clinical endpoints comparing Diclofenac Diethylamine Gel 1.16% of Encube Ethicals Private Limited, India with Voltaren Schmerzgel 11.6 mg/g (Diclofenac Diethylamine Gel 1.16%) of GlaxoSmithKline GmbH & Co. KG, 80258, Munich, Germany in patients with Osteoarthritis (OA) of the Knee.

IECCT/Pharmac/2024/394

Dr. Samir Dwidmuthe (PI)         

Dr. Chaitali Chindhalore-(Co-I)

INR 32240 per subject cost

Encube Ethicals Private Limited, India

Completed

No

A phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Pegozafermin in subjects with severe Hypertriglyceridemia (SHTG).

IECCT/Pharmac/2023.375

Dr. Sunita Kumbhalkar (PI)                        

Dr. Chaitali Chindhalore Co-I

INR 785,838 per completed subject

89bio, Inc

Ongoing

No

A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (EMBARK).

IECCT/Pharmac/2025/584

Dr. Srikant Malegaonkar (PI)

Dr. Chaitali Chindhalore (Co-I)

INR 614,563 per completed subject

AstraZeneca AB

Ongoing

No

A phase 3, randomized, double-blind, parallel group, placebo-controlled study to demonstrate the efficacy and safety of Milvexian, an Oral factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack.

IECCT/Pharmac/2024/446

Dr. Amruta Bagul (PI)

Dr. Anant Khot (Co-I)

INR 492,048 per completed subject

Janseen Research & Development

Ongoing

No

A non-randomized, non-interventional, prospective, multicenter, post marketing surveillance study to assess the antibacterial effectiveness and safety of 0.5% Moxifloxacin Hydrochloride Ophthalmic Solution in Perioperative (Preoperative and Postoperative) sterilization in patients undergoing Ophthalmic Surgery.

IECCT/Pharmac/2023/356

Dr. Puja Bang (PI)

Dr. Anant Khot (Co-I)

INR 12,500 per patient

Novartis Healthcare Ltd

Completed

No

 Knowledge, attitude and practices about research integrity/scientific misconduct among the Postgraduates and teaching faculty employed in Medical Institutes of Central India; A cross-sectional electronic survey

 IEC/2021/166

Dr Anant Khot

 Completed

 Yes

Impact of 5Ts - Timing, Infusion Type, Antibiotic Appropriateness, De-escalation Time and Diagnostic Stewardship on Clinical Outcome in Patients admitted in Intensive Care Units (ICUs): a multicenter retrospective cohort study"

 IEC/2024/884

 Dr Anant Khot

 NKP Salve Medical College, Nagpur

 Completed

 No

Perceived value and relevance of current practical pharmacology training for medical undergraduates in India: A qualitative exploratory study"

IEC/2025/677

Dr Anant Khot

Ongoing

No

Point Prevalence Survey of Antimicrobial Use in Paediatric ward, Neonatal and Paediatric Intensive Care Units in a Tertiary Care Hospital.”

IEC/2025/850

Dr Anant Khot

Ongoing

No

Effect of study design on the outcome of Real-World Evidence studies

IEC/2023/328

Snehalata Gajbhiye

Co PI:

Dakhale GA, Chindhalore CA

Ongoing

No

A cross-sectional study on the perceptions and barriers regarding therapeutic drug monitoring services in a tertiary care hospital.

IEC/2023/367

Snehalata Gajbhiye 

Co PI:

Dakhale GA, Chindhalore CA

Ongoing

No

Translation of Novel Pharmacological Therapies from Animal Studies to Clinical Trials in Psychiatric Diseases: A Systematic review.

IEC/2025/855

Snehalata Gajbhiye 

Co PI:

Sanket Gaikwad, Dakhale GA, Chindhalore CA

Ongoing

No

Evaluation of Factors of Various Stakeholders that Affect Decision to Participate in Paediatric Clinical Trial.

IEC/2025/818

Snehalata Gajbhiye 

Co PI:

Kalyani Pradhan, Dakhale GA, Chindhalore CA

Ongoing

No

IEC reference number

Title of research

IEC/Pharmac/2022/222

Comparative study of Efficacy, safety and cost effectiveness of Topical clindamycin 1% adapalene 0.1% combination therapy with oral Doxycycline versus Topical Benzoyl Peroxide 2.5% adapalene 0.1% combination therapy with oral Doxycycline in case of moderate to severe facial acne vulgaris: A Prospective, randomized open label parallel study

IEC/Pharmac/2024/445

Impact of educational intervention on over-the-counter Dispensing of antimicrobials by community pharmacists: A Cluster Randomized controlled Trial.

IEC/Pharmac/2024/751

Evaluation of effect of hydroxyurea on inflammatory markers and oxidative stress markers among adults with sickle cell disease: A prospective observational study

IEC/Pharmac/2024/997

Comparison of efficacy and safety of intravenous ferric carboxymaltose versus intravenous iron (III) isomaltoside 1000 in the treatment of patients with moderate to severe iron deficiency anemia: A prospective, randomized, open-labelled, active controlled study.

IEC/Pharmac/2025/1247

Comparative study of efficacy, safety and cost effectiveness of Minocycline 4% gel and Adapalene 0.1% - Benzoyl peroxide 2.5% combinationgel in mild to moderate facial Acne vulgaris: a prospective, randomized, open labelled parallel study

IEC/Pharmac/2025/1382

Impact of a Tailored Multimodal Educational Intervention on Medication Adherence and Rheumatoid Arthritis Disease Activity: A Randomized, Parallel-Group, Interventional Study.

IEC/Pharmac/2025/1421

To evaluate the effect of L-glutamine as an add-on to low-dose hydroxyurea on oxidative stress and clinical outcome in sickle cell anaemia - A prospective, open-label, randomized controlled study.

Year

Total no. Of publications

2019

3

2020

12

2021

3

2022

13

2023

13

2024

12

2025

12

Sr. No.

Publications in Vancouver Style

Impact Factor

Jire A, Chindhalore C, Motghare V, Dakhale G, Kalikar M, Turankar A. Acute effect of anti-anxiety drugs on psychomotor performance in healthy volunteers: a prospective, crossover study. IJMSCR. 2019; 2(3):374-83.

NA

Dr. Dakhale G, Hiware S, Turankar A. Basic statistical analysis for original studies (Chapter in Book). A guide to the scientific career in Shoja Mohammadali book. Nov 2019.

NA

Nama P, Parmar S, Gupta A, Ganesh D, Smita S. Angioneurotic Edema Due To Surgical Disposable Latex Gloves: A Case Report. International Journal of Current Advanced Research. 2019 June 28th;8(06):19146-19147.

NA

Sr. No.

Publications in Vancouver Style

Impact Factor

1

Kalikar M, Dakhale G, Shrirao M. Effect of educational intervention on awareness of pharmacovigilance among medical graduates in a tertiary care teaching hospital. Perspectives in clinical research. 2020, April june ,11(2):92-96.

~1.2

2

Sinha V, Giradkar A, Kalikar M, Dakhale G. A case of dapsone syndrome: a case report. Int J Pharm Sci Rev Res 2020, sep-oct ,64(1):73-7

NA

3

Chindhalore C, Dakhale G, Giradkar A. Comparison of self-medication practices with analgesics among undergraduate medical and paramedical students in central India-a questionnaire-based study. journal of education and health promotion 2020, Nov, 1-6

~1.7

4

Kadam RL, Sontakke SD, Tiple P, Motghare VM, Bajait CS, Kalikar MV. Comparative evaluation  of efficacy and tolerability of vilazodone, escitalopram and amitriptyline in patients of major depressive disorder: A randomized, parallel, open-label clinical study. Indian J Pharmacol 2020;52:79-85.

~1.3

5

Khot AM, Chaukimath SP, Janagond A, Hugar L. A Study of Cutaneous Adverse Drug Reactions; Clinical/Morphological Pattern & Causative Agents Reported in an ADR Monitoring Centre in a Tertiary Care Hospital of North Karnataka. Biomed Pharmacol J. 2020 Sep 25;13(3):1549–54.

NA

6

Inamdar SZ, Chirasani S, Janagond A, Londhe S, Katragadda P, Paramagond M, Kulkarni RV, Naikwadi A, Khot AM, Patil AV. Phenytoin Induced Steven Johnson Syndrome: A Case Report. Indian Journal of Pharmacy Practice. 2020 Nov 17. 13(4):373-76.

NA

7

Inamdar SZ, Jakanur S, Katragadda P, Janagond A, Paramagond M, Kulkarni RV, Naikwadi A, Khot AM, Patil AV. Drug Induced Hypersensitivity Syndrome Secondary to Phenobarbitone. Indian Journal8of Pharmacy Practice 13(3): 284-2869

NA

8

Chindhalore C, Dakhale G, Motghare V, Dr Upadhay A. Study of Drug Utilization Pattern of Corticosteroids in Dermatology at Tertiary Care Teaching Hospital. International Journal of Medical Science and Current Research (IJMSCR).Jan-Feb2020.vol-3.Issue-1.Page: 129-134

NA

9

Dakhale G, Kalikar M, GiradkarA, Sinha V. Perception of investigators about IEC of a tertiary care teaching hospital: a questionnaire-based study. International Journal of Current Advanced Research. March 2020. Vol- 9. Issue-3. Page: 21639-42 

NA 

10

KalikarM, Dakhale G, Shrirao M. Effect of educational intervention on awareness of pharmacovigilance among medical undergraduates in a a tertiary care teaching hospital. Perspectives in Clinical Research (PICR). May 2020. Vol-11. Issue-2. Page:92-6 

~1.2

11

Dakhale G, Dr. Gupta A, Dr.MukhiJ, Dr. Kalikar M. Comparison of efficacy, safety and cost effectiveness of sertaconazole vs luliconazole cream in patients with dermatophyses: A prospective randomized open label study. Perspectives in clinical research (PICR). Accepted 5/1/2020. 

~1.2

12

Chindhalore C, Dr. Dakhale G, Giradkar A. Comparison of self-medication practices with analgesics among undergraduate medical & paramedical students of tertiary care teaching institute in central India- A questionnaire-based study. Journal of education and health promotion. November 2020. Vol -9 

~1.7

Sr. No.

Publications in Vancouver Style

Impact Factor

1

Gajbhiye S, Koli PG, Harit M, Chitrakar M, Bavane V, Chawda M, Chitrakar MY. An evaluation of the efficacy, safety, and tolerability of abhraloha compared with oral ferrous ascorbate on iron deficiency anemia in women: a randomized controlled, parallel-group, assessor-blind clinical trial. Cureus. 2021 Apr 7;13(4). 

~1.2

2

Chindhalore C, Dakhale G, Umathe A. Assessment of knowledge, attitude and practice towards COVID-19 among paramedical staff in central India: A cross-sectional, online survey". Journal of education and health promotion. April 2021. 10(1):150.

~1.7

3

Dakhale GN, Gupta AV, Mukhi JI, Kalikar MV. Comparison of efficacy, safety, and cost-effectiveness of sertaconazole and luliconazole cream in patients with dermatophytoses: A prospective, randomized, open-label study. Perspect Clin Res 2021; 12:223-8 

~1.2

Sr. No.

Publications in Vancouver Style

Impact Factor

1

Gajbhiye S, Chindhalore C, Dakhale G, Gupta A. Impact of type of funding and conflicts of interest to outcome reported amongst the published studies of Covid-19. Indian Journal of Medical Ethics (IJME). DOI: 10.20529/IJME.2023.022.

~1.5

2

Tripathi R, Gajbhiye S, Jalgaonkar S, Khatri N, Sayyed M, Parkar S. Antipsychotic Drug Utilization and Adverse Drug Reaction Profiling in Patients With Schizophrenia at a Tertiary Care Hospital in Western India.    2022;  14(3):e23378.

~1.2

3

Shah A, Patankar R, Tripathi R, Jalgaonkar S, Sangtani N, Gajbhiye S.  Attitude and perception of post-graduate residents toward thesis: A cross-sectional study.  National Journal of Physiology, Pharmacy and Pharmacology.  2022;  12(7): 1-7. 

NA

4

Gajbhiye S. Under-reporting of safety data - cause for concern.  Journal of Postgraduate Medicine. 

~2.3

5

Dakhale G, Kalikar M, Sinha,  Giradkar A.   Analysis of Clinical trial agreement and Insurance policy submitted to Ethics committee of a tertiary care teaching Institute in central India.  Perspectives in Clinical Research (PICR).  July 2022; 13(3): 151-54.  

~1.2

6

Chindhalore C, Dakhale G, Gupta A, Gajbhiye S. Prescription analysis of antimicrobials and identifying predictors for prescribibg antibiotics in patients with with COVID 19 in central India.  Journal of clinical diagnosis and research.  Sept 2022; 16(9): FC 15-19.

~0.9

7

Chindhalore C, Dakhale G, Gupta A. Does educational intervention change knowledge, attitude and practice regarding pharmacovigilance among nursing officers in central India? An interventional study.  Journal of integrative nursing.  Sept 2022; 4(3): 114-19.

NA

8

Dakhale G, Kalikar M, Giradkar A.  Analysis of Serious Adverse Events: Review by an IEC of a tertiary care teaching hospital.  Perspectives in Clinical Research (PICR).  Oct 2022; 13(4): 189-94.

~1.2

9

Gajbhiye S, Bhangre A, Tripathi R, Jalgaonkar S, Arun S, Koli P. Evaluation of Antidepressant Effect of Minocycline in Alcohol Abstinence-Induced Depression Model in Mice. Cureus. 2022; 14(9): e28711

~1.2

10

Chindhalore C, Dakhale G, Kamble P, Rathod B, Kumbhalkar S, Phatak M. Effect of Ramipril on Cardiac Autonomic Neuropathy in Patients With Type II Diabetes Mellitus. Cureus. March 15, 2023; 15(3): e36209. DOI 10.7759/cureus.36209. 

~1.2

11

Chindhalore C, Dakhale G. Pharmacotherapy of diabetic neuropathy (Chapter in Book.  Advance research trends in medical and clinical sciences, MKSES publications, Lucknow, India. March 2023; Volume-I [Textbook] (ISBN:978-93-91248-55-0) : 51-61.

NA

12

Jalgaonkar S, Gajbhiye S, Sayyed M, Tripathi R, Khatri, N, Parmar U, Shankar A. S-adenosyl methionine improves motor co-ordination with reduced oxidative stress, dopaminergic neuronal loss, and DNA methylation in the brain striatum of 6-hydroxydopamine-induced neurodegeneration in rats. The Anatomical Record. 2023; 306 (4): 820-830

~2.1

Sr. No.

Publications in Vancouver Style

Impact Factor

1

Shetty YC, Tripathi R, Marathe PA, Jalgaonkar S, Gajbhiye SV, Katkar J. A retrospective study of ethics committee monitoring checklists of the audiovisual consent Process: An ethical perspective. Cureus. 2023; 15(1) : e34433.

~1.2

2

Dakhale GN, Kalikar MV, Chindhalore C, Tathod Y, Giradkar AB, Giri A. Medication adherence among patients on concomitant tuberculosis and antiretroviral regimen in a tertiary care teaching hospital. Natl J Pharmacol Ther. 2023;1(1):82-6.

NA

3

Gupta A, Akkilagunta S, Dakhale G, Chindhalore C, Deshmukh P. Active surveillance of adverse events following immunization for coronavirus disease 2019 vaccine (ChAdOx1) at a tertiary care teaching institute in Central India. Natl J Pharmacol Ther 2023;1:145-50.

NA

4

Gajbhiye S. Status of oral anticoagulant use in tertiary centre in South India. JPGM. 27th Nov 2023.

~2.3

5

Dakhale G, Kalikar M. Impact of accreditation on registered ethics committee in terms of quality and governance in India. PICR. April 24; 15(2):80-88. 

~1.2

6

Chindhalore C, Gupta A, Dakhale G, Shrivastava A. Analysis of cutaneous ADR reported at ADR monitoring centre in central India. Cureus. March 2024; 16(2): e53706DOI 10.7759.53706 

~1.2

7

Gajbhiye S, Vijayanand, Dakhale G, Chindhalore C. Evaluation of factors that act as barriers in conducting academic trials-an Investigator’s perspectives. PICR. April 24; 15(2):73-79.

~1.2

8

Chindhalore C. Voice of Basic Medical Scientist in Ethics Committee. EthiX Newsletter. 2024; 9:6-9.

NA

9

Singh S, Aggarwal A, Gudisa R, BatraP, Rathi N, Madan V, Thakur V, Sharma H, Kumar R, Khare S, Singhal L, Chaudhry R, Arora N, Singh H, Kaur J, Sharma A, Dakhale G, Sharma V,Gautam V. A Novel Potential Treatment for Diabetic Foot Ulcers and Non-Healing ulcers-case series.Infectious Disorders - Drug Targets, 2024, Vol. 24, No. 4:29-39

~2.5

Sr. No.

Publications in Vancouver Style

Impact Factor

1

Khot AM, Chindhalore CA, Naikwadi A. Knowledge, attitude, and practices about research integrity and scientific misconduct among the faculty and medical postgraduates working in medical colleges in north karnataka and central india: a cross-sectional online survey. Cureus. 2024; 16(4): e59200.

~1.2

2

Chindhalore C, Dakhale G, Gajbhiye S, Gupta A,Khapekar S. Analysis of informed consent documents for compliance with ICMR guidelines for biomedical and health research. Perspective in Clinical Research. 2024; 15:188-194.

~1.2

3

Parmar UI, Puradkar P, Kadam K, Tadavi F, Gajbhiye S, Joshi S, et al. An observational study to evaluate the awareness of drug treatment, prescription pattern, adverse drug reactions, and adherence in patients of major depressive disorder. Perspect Clin Res. 2024;15(2): 59-65.

~1.2

4

Chindhalore C, Dakhale G, Gajbhiye S. A crucial role of on-site clinical trial monitoring: Insights from the Ethics Committee. Perspectives in clinical research (accepted for publication).

~1.2

5

Gajbhiye S, Tripathi R, Jalgoankar S, Pohregaonkar A, Ourasang S. Evaluation of awareness and perception regarding conflict of interest in research among the postgraduate students in a tertiary care center. Journal of Pharmacology and Pharmacotherapeutics. 2024.

~1.1

6

Tripathi R, Shetty N, Jalgaonkar S, Gajbhiye S, Pillay S and Athavale A. Evaluation of Drug Treatment Awareness, Prescription Patterns and Perceived Drug Adherence in COPD Patients: Vital Determinants in COPD Management. International Journal of Contemporary Medical Research. 2024.

NA

7

Tripathi RK, Pilliwar C, Gajbhiye SV, Bhilwade SK, Jamale T. Evaluation of self-medication practices and prescription patterns in patients of chronic kidney disease: A cross-sectional, questionnaire-based study. Perspectives in Clinical Research. 2025. 16: 23-30.

~1.2

8

Jaju TA, Parmar UI, Gajbhiye SV, Kurle DG, Shah RM. Assessment of the effectiveness and perception of different teaching techniques used in pharmacology among students. Journal of Postgraduate Medicine. 2024; 70: 217-22

~2.3

9

Gajbhiye SV, Tripathi RK, Bade D, Jalgaonkar SV, Shankar A, Radhakrishnan M, Koli P. Evaluation of Minocycline in post-traumatic stress disorder induced in Wistar rats with alcohol use disorder. African Journal of Biological Sciences. 2024;6(5): 4671-4686.

NA

10

GBD 2021 HIV Collaborators. Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021. Lancet HIV. 2024;11(12): E807-E822.

~16.0

Sr. No.

Publications in Vancouver Style

Impact Factor

1

Dakhale G, Kalikar MV. Role of lay person in ethics committee: Bridging expertise and public trust. Perspectives in Clinical Research. 2025 Apr 1;16(2):99-101.

~1.2

2

Kumari N, Shamkuwar CA, Motghare VM, Dakhale GN, Motghare V. Comparative Efficacy and Safety of Daily Versus Alternate-Day Dosing of Rosuvastatin in Diabetic Dyslipidemia: An Open-Label Clinical Trial. Cureus. 2025 Jun 6;17(6).

~1.2

3

Chindhalore C, Dakhale GN, Emperumal TS, Dhal S. Stevens–Johnson syndrome/toxic epidermal necrolysis overlap syndrome due to a fixed-dose combination of aceclofenac, serratiopeptidase, and paracetamol. National Journal of Pharmacology and Therapeutics. 2025 Jan 1;3(1):69-71.

NA

4

Sorathiya, P., Desai, K.A., Kamble, P., Dube, S., Sahasrabuddhe, A., Chindhalore CA, Phatak, M., Umredkar, A. and Desai, K.A., 2025. Comparison of the Effects of Left, Right, and Bilateral Carotid Baroreceptor Stimulation on Autonomic and Hemodynamic Responses Using an Indigenously Developed Paired Neck Chamber Device. Cureus, 17(4).

~1.2

5

Gaikwad S, Jalgaonkar S, Tripathi R. Gastroprotective Effects of S-Adenosyl-L-Methionine Through Its Antioxidant and Anti-inflammatory Properties on Dextran Sulfate Sodium-Induced Chronic Colitis in Swiss Albino Mice. Cureus. 2025 Jun 16;17(6).

~1.2

6

Munshi R, Talmohite D, More A, Gajbhiye S. Ashwagandha, Withania somnifera (L.) Dunal, for the prophylaxis against SARS-CoV-2 infection: A multicentric randomized hydroxychloroquine controlled clinical trial in Indian health care workers. Journal of Ayurveda and Integrative Medicine. 2025 May 1;16(3):101135.

~2.7

7

Dakhale GN, Chindhaloe CA, Kumar M, Bidkar V. Effectiveness, safety, and cost-effectiveness of fixed-dose combination of montelukast–bilastine versus montelukast–levocetirizine in allergic rhinitis: A prospective, randomized, open-label, parallel-group study. Perspectives in Clinical Research. 2025:10-4103.

~1.2

8

Chindhalore CA, Mohod B, Gajbhiye S, Dakhale GN, Dhal S. Exploring Artificial Intelligence Integration in Indian Pharmacology: A Survey on Scope, Threats, and Challenges. Annals of African Medicine. 2023 Nov 24:10-4103.

~1.4

9

Parle S, Gajbhiye SV, Tadavi FM, More A, Biradar P, Chindhalore C, Dakhale GN, Pawar S. Evaluating patients’ approach toward participation in a clinical trial: A multicentric study. Perspectives in Clinical Research. 2025 Nov 11:10-4103.

~1.2

10

Shankpal PD, Lohi SM, Karande S, Bonde VN. A study of the prescription patterns of antihypertensive drugs in patients attending the outpatient department of medicine at a tertiary care hospital. Cureus. 2025 Jul 18;17(7).

~1.2

11

Lohi S M, Chindhalore C A, Dakhale G, Gajbhiye S. Cost Variation and Affordability of Oral Targeted Cancer Therapy in India: Comparison of Branded and Janaushadhi Products. Cureus 17(12): e100287. doi:10.7759/cureus.100287.

~1.2

12

Chavan RR, Badar VA, Gaikwad P, Pradhan K. Drug utilization study in various types of acne and drug therapy variations according to age and severity in the outpatient department of dermatology in a tertiary care centre: an observational study. Int J Pharm Sci Rev Res. 2025;85(9):36–40. doi:10.47583/ijpsrr.2025.v85i09.007.

NA

13

Yadav R, Chaudhary JK, Bisht K, Dhamija P, Chaudhary PK, Nath UK, Jain N. Multiple myeloma: Insights into underlying mechanisms, advances in diagnostic and therapeutic modalities. Semin Oncol. 2025 Oct;52(5):152390. Doi: 10.1016/j.seminoncol.2025.152390.

~2.5